Canada NewsWire
MISSISSAUGA, ON , May 2, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial results for the first quarter of 2025 after the market close on Thursday, May 8, 2025 . The Company will also hold a conference call on Friday, May 9, 2025 at 8:30am ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
|
DATE: |
Friday, May 9, 2025 |
|
|
|
|
TIME: |
8:30 a.m. ET |
|
|
|
|
DIAL-IN NUMBER: |
416-945-7677 or 888-699-1199 |
|
|
|
|
REPLAY: |
289-819-1450 or 888-660-6345 Code: 69080# |
|
|
|
|
|
Expires: May, 16, 2025 |
|
|
|
|
WEBCAST: |
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada , the U.S., and South America . For more information, visit www.cipherpharma.com .
SOURCE Cipher Pharmaceuticals Inc.
View original content:
http://www.newswire.ca/en/releases/archive/May2025/02/c5412.html
